Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Chubb
Queensland Health
QuintilesIMS
Cipla
Deloitte
Teva
Boehringer Ingelheim
Julphar

Generated: June 20, 2018

DrugPatentWatch Database Preview

PROPECIA Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Propecia patents expire, and when can generic versions of Propecia launch?

Propecia is a drug marketed by Merck and is included in one NDA.

The generic ingredient in PROPECIA is finasteride. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the finasteride profile page.
Drug patent expirations by year for PROPECIA
Pharmacology for PROPECIA
Medical Subject Heading (MeSH) Categories for PROPECIA
Synonyms for PROPECIA
(17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one
(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-3-ene-14-carboxamide
(1S,2R,7R,10S,11S,14S,15S)-N-TERT-BUTYL-2,15-DIMETHYL-5-OXO-6-AZATETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-3-ENE-14-CARBOXAMIDE
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-Butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,1
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
(4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
(5ALPHA,17BETA)-N-(1,1-DIMETHYLETHYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE
(R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
1,(5ALPHA)-ANDROSTAN-4-AZA-3-ONE-17BETA-(N-TERT-BUTYL-CARBOXAMIDE)
17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one
17BETA-(N-TERT-BUTYLCARBAMOYL)-4-AZA-5ALPHA-ANDROST-1-EN-3-ONE
319F267
32329-EP2272827A1
32329-EP2275420A1
32329-EP2280012A2
32329-EP2281815A1
32329-EP2292615A1
32329-EP2295055A2
32329-EP2295416A2
32329-EP2295426A1
32329-EP2295427A1
32329-EP2298748A2
32329-EP2298764A1
32329-EP2298765A1
32329-EP2298768A1
32329-EP2301928A1
32329-EP2301933A1
32329-EP2305640A2
32329-EP2305642A2
32329-EP2305671A1
32329-EP2311453A1
32329-EP2311808A1
32329-EP2311825A1
32329-EP2311827A1
32329-EP2311829A1
32329-EP2311840A1
4-azaandrost-1-ene-17-carboxamide, N -(1,1-dimethylethyl)-3-oxo-,(5(alpha),17(beta))-
4-azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha, 17beta)-
4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-
4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)-
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide
4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide(Finasteride)
4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid (Finasteride)
57GNO57U7G
98319-26-7
AB00513901
AB00513901_09
AB00513901-07
AB00513901-08
AB07586
AB1008360
AC1L1MUF
AC1Q5L2C
ACT02599
AJ-45596
AK-72879
AKOS015894916
Alternova (TN)
AN-615
Andozac
Appecia (TN)
BC200264
BCP0726000222
BCP9000685
BCPP000229
BDBM50334788
BPBio1_001027
BR-72879
BRD-K01095011-001-03-5
BRN 4269024
BSPBio_000933
C-34893
C23H36N2O2
Cahill May Roberts Brand of Finasteride
CAS-98319-26-7
CC-28426
CCG-100937
CCRIS 7438
CHEBI:5062
CHEMBL710
Chibro Proscar
Chibro-Proscar
CPD000466304
CS-1767
D00321
D08IWD
DB01216
DBEPLOCGEIEOCV-WSBQPABSSA-N
DSSTox_CID_625
DSSTox_GSID_20625
DSSTox_RID_75699
DTXSID3020625
Eucoprost
Finalo (TN)
Finara (TN)
Finast (TN)
Finasterid (TN)
Finasterid IVAX (TN)
Finasterida
Finasterida [INN-Spanish]
finasteride
Finasteride (JAN/USP/INN)
Finasteride (Proscar)
Finasteride (USP/INN)
Finasteride [USAN:INN:BAN]
Finasteride [USAN:USP:INN:BAN]
Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard
Finasteride, >=98% (HPLC), powder
Finasteride, British Pharmacopoeia (BP) Reference Standard
Finasteride, European Pharmacopoeia (EP) Reference Standard
Finasteride, United States Pharmacopeia (USP) Reference Standard
Finasteride, VETRANAL(TM), analytical standard
Finasteridum
Finasteridum [INN-Latin]
Finastid
Finax (TN)
Fincar (TN)
Finpecia
Finpecia (TN)
Frosst Iberica Brand of Finasteride
FT-0082891
Gefina (TN)
GTPL6818
HMS1570O15
HMS2051F09
HMS2090G22
HMS2097O15
HMS2235L23
HSDB 6793
HY-13635
J10122
KS-1058
L-652,931
Lipha Brand of Finasteride
LS-7397
Merck Brand 1 of Finasteride
Merck Brand 2 of Finasteride
Merck Frosst Brand 1 of Finasteride
Merck Frosst Brand 2 of Finasteride
Merck Sharp & Dhome Brand 2 of Finasteride
Merck Sharp & Dohme Brand 1 of Finasteride
MFCD00869737
MK 0906
MK 609
MK 906
MK-0906
MK-906
MK906
MLS000759404
MLS001165768
MLS001424046
MolPort-002-500-272
MSD Brand of Finasteride
MSD Chibropharm Brand of Finasteride
N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide
N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
N-tert-Butyl-3-oxo-4-aza-5|A-androst-1-en-17|A-carboxamide; N-(2-Methyl-2-propyl)-3-oxo-4-aza-5|A-androst-1-ene-17|A-carboxamide
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide
N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
NC00187
NCGC00016965-01
NCGC00093560-05
NCGC00256334-01
NCGC00259057-01
NSC-741485
NSC741485
PL001776
Prestwick0_000717
Prestwick1_000717
Prestwick2_000717
Prestwick3_000717
Propecia (TN)
Propeshia
Proscar
Proscar (TN)
Proscar, Propecia, Finasteride
Prosteride
Prosteride (TN)
Prostide
s1197
SC-12178
SCHEMBL5509
SMR000466304
SPBio_002854
SR-01000759414
SR-01000759414-6
ST2419391
Tox21_110717
Tox21_110717_1
Tox21_201506
Tox21_302744
UNII-57GNO57U7G
X-2990
YM-152
ZINC3782599

US Patents and Regulatory Information for PROPECIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for PROPECIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PROPECIA finasteride TABLET;ORAL 020788-001 Dec 19, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Department of Justice
US Army
Colorcon
McKinsey
Fish and Richardson
Harvard Business School
Cipla
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.